Vedolizumab for stricturing Crohn’s disease of the terminal ileum – an international multicenter cohort study
Abstract Objective Crohn’s disease (CD) frequently progresses to stricturing complications. Anti-stricture therapies are lacking, and anti-inflammatory therapies are hence the mainstay of medical treatment. However, data on the efficacy of vedolizumab in stricturing CD are not available. We therefor...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2026-05-01
|
| Serier: | BMC Gastroenterology |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12876-026-04815-4 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
